Literature DB >> 23012671

Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients?

Carmine Finelli1, Giovanni Tarantino.   

Abstract

In this article, we review the current concepts about the pathogenesis of hepatic steatosis and non-alcoholic steatohepatitis and evaluate the existing diets in the context of this knowledge and the available literature. The intent is to enable clinicians to evaluate the diets of non-alcoholic fatty liver disease (NAFLD) patients and make rational decisions based on this perspective - in the absence of controlled trials - to help their patients. Finally, a tailored approach for the dietary treatment of NAFLD is offered as a way to optimize the dietary management of this condition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23012671

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  25 in total

Review 1.  Exposure to ambient air particulate matter and non-alcoholic fatty liver disease.

Authors:  Giovanni Tarantino; Domenico Capone; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

Review 2.  The role of the gut microbiota in NAFLD.

Authors:  Christopher Leung; Leni Rivera; John B Furness; Peter W Angus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

Review 3.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 4.  Liver-spleen axis: intersection between immunity, infections and metabolism.

Authors:  Giovanni Tarantino; Antonella Scalera; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

5.  Fatty acid changes help to better understand regression of nonalcoholic fatty liver disease.

Authors:  Dominika Maciejewska; Arleta Drozd; Piotr Ossowski; Karina Ryterska; Dominika Jamioł-Milc; Marcin Banaszczak; Joanna Raszeja-Wyszomirska; Małgorzata Kaczorowska; Anna Sabinicz; Ewa Stachowska
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 6.  Promising therapies for treatment of nonalcoholic steatohepatitis.

Authors:  Mazen Noureddin; Alice Zhang; Rohit Loomba
Journal:  Expert Opin Emerg Drugs       Date:  2016-08-28       Impact factor: 4.191

Review 7.  Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes.

Authors:  Jill L Sherriff; Therese A O'Sullivan; Catherine Properzi; Josephine-Lee Oddo; Leon A Adams
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

Review 8.  Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?

Authors:  Naga S Betrapally; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Gastroenterology       Date:  2016-03-04       Impact factor: 22.682

Review 9.  Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.

Authors:  Oriol Juanola; Sebastián Martínez-López; Rubén Francés; Isabel Gómez-Hurtado
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

Review 10.  Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities.

Authors:  Anna Hernández-Aguilera; Anna Rull; Esther Rodríguez-Gallego; Marta Riera-Borrull; Fedra Luciano-Mateo; Jordi Camps; Javier A Menéndez; Jorge Joven
Journal:  Mediators Inflamm       Date:  2013-02-28       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.